Phase IV Clinical Study
Phase IV Clinical Study. Means a clinical study initiated after a Product has been granted Regulatory Approval in Japan, and which is aimed at strengthening the clinical evidence for such Product to be used in the Commercialization of such Product.
All Definitions
Found in
Durata Therapeutics, Inc. contract